The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Curis
Stock and Other Ownership Interests - Curis
Emavusertib (CA-4948) in combination with ibrutinib in patients with relapsed/refractory primary central nervous system lymphoma (R/R PCNSL).
 
Christian Grommes
Consulting or Advisory Role - Curis; Ono Pharmaceutical; Roche
Speakers' Bureau - Curis; Ono Pharmaceutical
Research Funding - Curis
Travel, Accommodations, Expenses - Ono Pharmaceutical
 
Han W. Tun
Honoraria - ADC Therapeutics; Gossamer Bio
Consulting or Advisory Role - Gossamer Bio
Research Funding - Acrotech Biopharma (Inst); Curis (Inst); DTRM (Inst)
Travel, Accommodations, Expenses - Acrotech Biopharma
 
Adolfo de la Fuente Burguera
Honoraria - Abbvie; Astellas Pharma; Celgene- BMS; Curis; Daiichi Sankyo; ImmunoGen; Incyte; Jazzpharm; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Astellas Amgen BioPharama; Celgene/Bristol-Myers Squibb; Curis; Daiichi Sankyo; ImmunoGen; Incyte; Jazz Pharmaceuticals; Novartis Biociencias; Pfizer; Roche Africa
Speakers' Bureau - Curis
Research Funding - BTG; Cilag; Janssen Oncology; Novartis
 
Anna Dabrowska-Iwanicka
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Lucia Regales
Employment - Curis
Stock and Other Ownership Interests - Curis
 
Wanying Zhao
Employment - Curis; Merck (I)
Stock and Other Ownership Interests - Curis; Incyte
 
Dora Ferrari
No Relationships to Disclose
 
Meaghan Fowles
No Relationships to Disclose
 
Maureen E Lane
Employment - Curis
Leadership - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
 
Catherine Wang
Employment - Curis
Stock and Other Ownership Interests - Curis
 
Reinhard W. Von Roemeling
Employment - Curis
Leadership - Curis
Stock and Other Ownership Interests - Curis
 
Michal Taszner
Research Funding - Curis (Inst)
 
Christopher D'angelo
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Ono Pharmaceutical; Seagen
Research Funding - BeiGene; Bristol Myers Squibb Foundation; Fate Therapeutics; Ono Pharmaceutical
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Bantam Pharmaceutical; Celgene (Inst); Debiopharm Group; Genentech (Inst); Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)